Akebia Therapeutics to Report Second Quarter Financial Results

Go back to Akebia Therapeutics to Report Second Quarter Financial Results
AKEBIA THERAPEUTICS (NASDAQ: AKBA) Delayed: 0.98 +0.04 (4.26%)
Previous Close $0.94    52 Week High $13.20 
Open $0.95    52 Week Low $7.00 
Day High $1.01    P/E N/A 
Day Low $0.95    EPS $0.00 
Volume 6,555,713